Oramed Pharmaceuticals Stock (NASDAQ: ORMP) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.95K / 125.50K |
Day Range | - - - |
52 Wk Range | 1.67 - 3.67 |
Market Cap | $106.04M |
P/E Ratio | 10.12 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 1.43% |
Days to Cover | 2.04 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Oramed Pharmaceuticals (NASDAQ:ORMP) through any online brokerage.
Other companies in Oramed Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Universe Pharmaceuticals (NASDAQ:UPC), Rani Therapeutics Hldgs (NASDAQ:RANI), Marinus Pharma (NASDAQ:MRNS) and Nutriband (NASDAQ:NTRB).
There is no analysis for Oramed Pharmaceuticals.
Oramed Pharmaceuticals has a consensus price target of $20.50.
The stock price for Oramed Pharmaceuticals (NASDAQ: ORMP) is $2.61 last updated Today at July 24, 2024 at 7:10 AM EDT.
There are no upcoming dividends for Oramed Pharmaceuticals.
Oramed Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Oramed Pharmaceuticals.
Oramed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.